Ernexia Therapeutics Inc. Registration Statement Declared Effective
Ticker: ERNA · Form: EFFECT · Filed: Mar 31, 2026 · CIK: 0000748592
| Field | Detail |
|---|---|
| Company | Ernexa Therapeutics INC. (ERNA) |
| Form Type | EFFECT |
| Filed Date | Mar 31, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
TL;DR
Ernexia's registration is officially effective as of 3/30/2026. Go time!
AI Summary
Ernexia Therapeutics Inc. filed an EFFECT form on March 31, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-000994, was accepted at 00:15:33. The effectiveness date is noted as March 30, 2026.
Why It Matters
This filing signifies that Ernexia Therapeutics Inc. has met the SEC's requirements for its registration statement, allowing it to proceed with its planned securities offering.
Risk Assessment
Risk Level: low — This is a routine administrative filing indicating the effectiveness of a registration statement, not a filing that inherently carries significant new risks.
Key Numbers
- 2026-03-30 — Effectiveness Date (The date the registration statement became effective.)
- 2026-03-31 — Acceptance Date (The date the SEC accepted the filing.)
Key Players & Entities
- Ernexia Therapeutics Inc. (company) — Filer
- 0000748592 (company) — CIK number for Ernexia Therapeutics Inc.
- 333-294307 (dollar_amount) — File number for the registration statement
FAQ
What type of filing is this?
This is a Form EFFECT, which is a Notice of Effectiveness for a registration statement.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-000994.
When did the registration statement become effective?
The registration statement became effective on March 30, 2026.
What is the CIK number for Ernexia Therapeutics Inc.?
The CIK number for Ernexia Therapeutics Inc. is 0000748592.
What is the File Number associated with this registration?
The File Number is 333-294307.
Filing Stats: 33 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2026-03-31 00:15:33
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-000994.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: March 30, 2026 4:30 P.M. Form: S-3 CIK: Company Name: Ernexa Therapeutics Inc. File Number: 333-294307